You are here

  • Home
  • Archive
  • Volume 3, Issue 4
  • Aspirin treatment and risk of first incident cardiovascular diseases in patients with type 2 diabetes: an observational study from the Swedish National Diabetes Register

Article metrics

Article menu
XML
Diabetes and endocrinology
Research
Aspirin treatment and risk of first incident cardiovascular diseases in patients with type 2 diabetes: an observational study from the Swedish National Diabetes Register

 

Online download statistics by month:

Online download statistics by month: January 2018 to November 2024

AbstractFullPdf
Jan 201841332
Feb 201832265
Mar 201843408
Apr 201833271
May 2018594310
Jun 201829193
Jul 201841317
Aug 201849434
Sep 201834301
Oct 201849479
Nov 201842304
Dec 201831314
Jan 201922222
Feb 2019212212
Mar 201940383
Apr 201974719
May 201933339
Jun 201926267
Jul 201928283
Aug 201923235
Oct 201921214
Nov 201929282
Dec 201933334
Jan 202034344
Feb 2020403610
Mar 202029273
May 2020313110
Jun 202023193
Jul 2020222110
Aug 202020183
Sep 202034345
Oct 202031298
Nov 202021219
Dec 202038315
Jan 2021635718
Feb 202139396
Mar 202134346
Apr 202153541
May 202120205
Jun 202116164
Jul 202112127
Aug 2021232210
Sep 202117168
Oct 2021191820
Nov 2021232221
Dec 202141375
Jan 202241345
Feb 202230281
Mar 202231305
Apr 202231307
May 202224249
Jun 202222218
Jul 202212112
Aug 202242406
Sep 202229298
Oct 202237298
Nov 202222248
Dec 202217153
Jan 2023191817
Feb 202315120
Mar 2023888
Apr 202310103
May 202313119
Jun 202317141
Jul 2023111110
Aug 2023111111
Sep 2023151511
Oct 202316160
Nov 202330146
Dec 202331307
Jan 202430302
Feb 202429308
Mar 2024434140
Apr 202435359
May 202470661
Jun 202464626
Jul 2024524813
Aug 202457519
Sep 202438367
Oct 2024504613
Nov 202431313
Total25492354563